UK government clears animal to human transplant trials under strict guidelines
This article was originally published in Clinica
The UK government has set out new guidelines that allow companies to begin clinical trials of medical devices which use live animal cells, if they can convince a panel of experts and ministers that they are safe.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.